CellWell record HH-50413
Potassium supplementation lowers blood pressure and increases urinary kallikrein in essential hypertensives
Valdés G; Vio CP; Montero J; Avendaño R
Journal of human hypertension · 1991
In plain language
In 24 untreated hypertensive patients, four weeks of potassium chloride supplementation lowered blood pressure by several points and raised urinary kallikrein, a kidney enzyme linked to blood vessel dilation, compared with placebo.
- Evidence
- Established
- Design
- Randomized controlled trial
Cite this record: https://thecellwell.org/studies/HH-50413
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.